FIH Lead-in Study of YASO GEL Followed by a Phase 1 Randomized, Double-blind Study to Assess Safety and Pharmacokinetics of YASO GEL

NCT07281404 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

NOT_YET_RECRUITING

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Early-phase Safety and PK Study of a Vaginal Gel

Interventions

DRUG: YASO GEL
DRUG: Placebo gel

Sponsor

Yaso Therapeutics Corporation

Collaborators

[object Object]
[object Object]